Breaking news in heart failure: ESC Guidelines 2016, non-steroidal mineralocorticoid receptor antagonist, and alternate site CRT pacing

被引:0
|
作者
Luescher, Thomas F. [1 ]
机构
[1] Zurich Heart House,Careum Campus,Moussonstr 4, CH-8091 Zurich, Switzerland
关键词
CARDIOVASCULAR RISK; OUTCOMES; ASSOCIATION; EPLERENONE; FINERENONE;
D O I
10.1093/eurheartj/ehw306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2085 / 2087
页数:3
相关论文
共 45 条
  • [31] PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
    Orena, Stephen
    Maurer, Tristan S.
    She, Li
    Eudy, Rena
    Bernardo, Vincent
    Dash, Darla
    Loria, Paula
    Banker, Mary E.
    Tugnait, Meera
    Okerberg, Carlin V.
    Qian, Jessie
    Boustany-Kari, Carine M.
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [32] Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
    Pitt, Bertram
    Kober, Lars
    Ponikowski, Piotr
    Gheorghiade, Mihai
    Filippatos, Gerasimos
    Krum, Henry
    Nowack, Christina
    Kolkhof, Peter
    Kim, So-Young
    Zannad, Faiez
    EUROPEAN HEART JOURNAL, 2013, 34 (31) : 2453 - 2463
  • [33] Non-steroidal mineralocorticoid receptor antagonist, finerenone, attenuates obesity- and hypertension-induced cardiomyocyte hypertrophy in a blood pressure-independent manner
    Morikawa, K.
    Arima, Y.
    Fujiyama, A.
    Yamada, T.
    Hanatani, S.
    Yamamoto, E.
    Tsujita, K.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [34] The Non-Steroidal Mineralocorticoid Receptor Antagonist KBP-5074 Limits Albuminuria and has Improved Therapeutic Index Compared With Eplerenone in a Rat Model With Mineralocorticoid-Induced Renal Injury
    Jaisser, Frederic
    Tan, Xiaojuan
    Chi, Shuangshuang
    Liu, Jinrong
    Wang, Ping
    Bush, Mark
    Benn, Vincent
    Yang, Y. Fred
    Zhang, Jay
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [35] Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy
    Jerome, Jack R.
    Deliyanti, Devy
    Suphapimol, Varaporn
    Kolkhof, Peter
    Wilkinson-Berka, Jennifer L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [36] SM-368229, A Novel Non-Steroidal Mineralocorticoid Receptor Antagonist With Partial Agonistic Activity, Shows Minimal Effect on Serum Potassium Level in Rats
    Nariai, Tetsuro
    Fujita, Katsuya
    Mori, Masaya
    Katayama, Seiji
    Hori, Seiji
    Matsui, Kazuki
    HYPERTENSION, 2011, 58 (05) : E84 - E84
  • [37] CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats
    Arai, Kiyoshi
    Tsuruoka, Hiroyuki
    Homma, Tsuyoshi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 769 : 266 - 273
  • [38] EFFECTS OF ESAXERENONE (CS-3150), A NON-STEROIDAL SELECTIVE OF MINERALOCORTICOID RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND RENAL INJURY IN DAHL SALT-SENSITIVE RATS
    Lei, Li
    Nishiyama, Akira
    JOURNAL OF HYPERTENSION, 2018, 36 : E18 - E18
  • [39] Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K/Akt/eNOS signaling pathway in diabetic tubulopathy
    Yao, Lan
    Liang, Xianhui
    Liu, Yamin
    Li, Bingyu
    Hong, Mei
    Wang, Xin
    Chen, Bohan
    Liu, Zhangsuo
    Wang, Pei
    REDOX BIOLOGY, 2023, 68
  • [40] Finerenone, a novel selective non-steroidal mineralocorticoid receptor antagonist with a balanced cardiorenal tissue distribution confers pronounced end organ protection at low natriuretic doses
    Kolkhof, P.
    Delbeck, M.
    Kretschmer, A.
    Steinke, W.
    Hartmann, E.
    Baerfacker, L.
    Eitner, F.
    Albrecht-Kuepper, B.
    Schaefer, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 210 - 210